Advertisement
Screener

NEXGEL, INC. (NXGL) Form D

NEXGEL, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2021-09-17: Federal exemption Rule 506(b); Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2021-09-02; Total offering amount $2,500,000.
  • 2021-03-23: Federal exemption Rule 506(b); Types of securities offered Debt; SecurityToBeAcquired; Date of first sale 2021-03-11; Total offering amount $1,500,000.
  • 2021-03-23: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2020-11-25; Total offering amount $515,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2021-09-17Rule 506(b)Debt; SecurityToBeAcquired2021-09-02$2,500,000$1,620,000$880,00020
2021-03-23Rule 506(b)Debt; SecurityToBeAcquired2021-03-11$1,500,000$1,500,000$01
2021-03-23Rule 506(b)Equity; OptionToAcquire2020-11-25$515,000$515,000$012

Similar stocks

Stock NameCountryMarket CapPE Ratio
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23
Tenon Medical, Inc. (TNON)United States$0.002B
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Profusa, Inc. (PFSA)United States$0.002B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B